Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

A Digital Pathology Addendum 2020
|
2020
Global Digital Pathology 2019
|
2020

Related Segments

 End chart zoom
US Digital Pathology 2022 US Digital Pathology 2022
* A page refresh may be necessary to see the updated image

US Digital Pathology 2022
Early Adopters Lead the Charge in an Emerging Market

author - Eder Lagemann
Author
Eder Lagemann
author - Sidney Tate
Author
Sidney Tate
 
September 29, 2022 | Read Time: 4  minutes

Digital pathology for primary diagnosis is nascent in the US, but it is primed for rapid growth, similar to what is currently being seen in Europe (see KLAS’ report on global digital pathology). In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction. 33 of the interviewed organizations are live with digital pathology; the rest are currently implementing or making plans for the future.

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.

Key Findings:

  1. State of Digital Pathology among Early US Adopters
  2. Digital Pathology Technology Use
  3. Leica, Philips Lead in Busy IMS Market
  4. Leica & Philips Scanners Selected Most Frequently with Own IMS; Hamamatsu, Roche & 3DHISTECH Most Common for Third-Party Pairings
author - Elizabeth Pew
Writer
Elizabeth Pew
author - Madison Moniz
Designer
Madison Moniz
author - Jill Wilcock
Project Manager
Jill Wilcock
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

Related Segments